Adrian Vella, MD
Mayo Clinic
19
19
10
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+20 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (19)
Showing 10 of 19 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Samuel Klein, MD
Washington University School of Medicine
Shared therapeutic areas:
Worked with same sponsors:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Suman Wason, MD
Lexicon Pharmaceuticals, Inc.
Shared therapeutic areas:
Timothy Bailey, MD
AMCR Institute
Shared therapeutic areas:
Worked with same sponsors:
Shirley Wang, PhD, ScM
Brigham and Women's Hospital
Shared therapeutic areas:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Worked with same sponsors:
Meral Boşnak Güçlü, Prof. Dr.
Gazi University
Shared therapeutic areas:
David s Ludwig, MD, PhD
Boston Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (19)
Showing 19 of 19 trials
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Secretion
Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin Secretion
Genetic Variation in OCT1 and Response to Metformin
Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin
The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics
Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss
Vagal Nerve Stimulation and Glucose Metabolism
Dose-response Study of Exendin-9,39 on Glucose Metabolism
A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans
All 19 trials loaded